Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
4.430
+0.040 (0.91%)
At close: Aug 1, 2025, 4:00 PM
4.420
-0.010 (-0.23%)
After-hours: Aug 1, 2025, 6:04 PM EDT
Smartsheet Market Cap
Neuronetics has a market cap or net worth of $292.22 million as of August 1, 2025. Its market cap has increased by 387.08% in one year.
Market Cap
292.22M
Enterprise Value
354.54M
1-Year Change
387.08%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $292.22M, a decrease of -37.13%. That is a compound annual growth rate of -6.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 292.22M | 226.14% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | 210.82M | 151.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.69B |
| Johnson & Johnson | 401.28B |
| AbbVie | 346.46B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 230.38B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |